Query
Find articles
Pick a keyword, optionally a second one to combine it with (and, or, either but not both, or but not), then narrow the articles down by text, source and time range. Keywords update the results right away; filters apply with their button.
Query
How they overlap
Of the articles on each keyword in the last 7 days, with the same text and sources, how many also mention the other. Per lean: the share of its outlets' articles on cancer that mention cancer vaccine.
3.4% of the 59 articles on cancer also mention cancer vaccine, as do 100.0% of the 2 articles on cancer vaccine.
- Left-leaning0 of 22 articles
- 0.0%
- Least biased0 of 7 articles
- 0.0%
- Right-leaning2 of 30 articles
- 6.7%
Who picked it up when
The Washington Times mentioned it first (Oct 22, 2026, 6:23 PM EDT). No left-leaning outlet mentioned it. No least biased outlet mentioned it.
One row per source with a matching article, from the most left-leaning on top: a dot for each article, on a bar for each stretch of its coverage (a pause of more than 24 hours starts a new one). Hover or tap a dot for the headline, click it to read the article.
Source lean:leftcenterright
Source leans by Media Bias/Fact Check.
Results
2 articles mention cancer and cancer vaccine in the last 7 days (Oct 21 to Oct 27).
| Article | |||
|---|---|---|---|
| The Daily Wire | Personalized Cancer Vaccine Shows Promise In Major TrialThe Daily Wire Pharmaceutical companies Merck and Moderna reported that an experimental personalized mRNA vaccine, given alongside the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence or death by 42% compared with Keytruda alone. The Phase 3 trial included 1,137 patients with Stage IIB-IV melanoma whose tumors had been surgically removed. The findings could bring the drugmakers ... | 0.80● | |
| The Washington Times | A novel mRNA cancer vaccine helps reduce the chances of melanoma patients' tumors returningThe Washington Times A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. | 0.75● |
Source leans by Media Bias/Fact Check.
Narrow further
Other keywords in the matching articles: the share of them that mention each, with the number of articles.
No other keyword appears in more than one of the matching articles.
Coverage by source
The share of each source's stories in the last 7 days that match the query, from left to right. Sort the table to reorder the bars.
Source lean:leftcenterright
Source leans by Media Bias/Fact Check.
| The Washington Times | 0.3% | 1 | 322 |
| The Daily Wire | 0.5% | 1 | 205 |
Coverage by lean
The share of stories that match the query, in the last 7 days, averaged over the outlets of each political lean with at least 3 stories. The groups differ in size, so a single outlet weighs more in the smaller ones.
- Left-leaning0 of 15 sources
- 0.0%
- Least biased0 of 8 sources
- 0.0%
- Right-leaning2 of 15 sources
- 0.1%
Lean index +7.2: covered more by right-leaning outlets
Each outlet at its MBFC bias score, from −10 (far left) to +10 (far right), as high as the share of its stories that match the query. The lean index is the average score of the outlets covering it, weighted by that share.
lean indexour sources' average (+0.4)leftcenterright
Bias scores by Media Bias/Fact Check.
1 source has no MBFC bias score and is not shown.
Source leans based on ratings by Media Bias/Fact Check.